Pinealon for Chemotherapy-Induced Neuropathy: Evidence-Graded Review
What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
Why Pinealon might help you
- You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.
- Therefore for you: If that layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.
Why Gabapentin / pregabalin matters for you
- Drug: Gabapentin / pregabalin
- What it does: Masks neuropathic pain signal; does not repair nerve.
- Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- Pinealon → neural / pineal
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 4
- Claims tagged human evidence: 3
- Claims tagged preclinical (animal/lab): 1
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 4
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.5 / 1.00 — low–moderate — mostly preclinical
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
EDR Peptide: Possible Mechanism of Gene Expression and Neuroprotection (source s1)
Overview of Pinealon research; no CIPN mention.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Pinealon Increases Cell Viability by Suppression of Free Radical Levels (source s2)
In vitro rat neuron study on ROS and viability.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
New Practical Approaches to Chemotherapy-Induced Neuropathic Pain (source s3)
Review of CIPN pharmacologic evidence.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Peptide Regulation of Gene Expression: A Systematic Review (source s4)
Systematic review citing Pinealon neuroprotective data.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 4 · tier-ranked · API
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/pinealon-chemo-neuropathy/contributionsAsk this article · 6 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.